Chennai: Apollo Hospitals Group has announced a partnership with India Medtronic Private Limited to integrate Artificial Intelligence (AI) for advanced stroke management for the first time in India.
The USFDA approved AI platform for stroke diagnosis has been validated by clinical trials.
The AI software will provide automated analysis in less than two minutes as against currently accepted imaging practices for diagnosis of stroke that takes up to one hour to complete, enabling faster decision making in stroke where every second counts.
Hospital chairman Dr Prathap C Reddy told a virtual press meet that through this partnership, Medtronic will help in bringing in stroke technologies, technical expertise, training and comprehensive stroke management with the integration of AI platform at the Apollo Institute of Neurosciences at ten locations across the country, taking stroke management to the next level by standardizing stroke diagnosis and empowering clinicians to make faster, more accurate diagnosis andĀ treatment decisions.
He said stroke was a major global public health problem with one in 4 people over the age of 25 years suffering a stroke during their lifetime, according to data from the World Stroke Organisation.
It was the fourth leading cause of death today and 1.8 million people in India suffer from a stroke every year and only early treatment could reduce morbidity and mortality.